MSD commences Phase III trial of DLBCL treatment
MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...
GENFIT S.A.: GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b ...
Earnings call transcript: Acelia Pharma's Q4 2024 sees extended cash runway
Acelia Pharma reported its Q4 2024 earnings, focusing on its strategic advancements and financial stability. The company announced an operating loss of 21.9 million kronor, while maintaining a cash ...